Abstract
Extracellular vesicles (EVs) act as cell communicators and immune response modulators and may be employed as disease biomarkers and drug delivery systems. In infectious diseases, EVs can be released by the pathogen itself or by the host cells (infected or uninfected), potentially impacting the outcome of the immune response and pathological processes. Chagas disease (CD) is caused by infection by the protozoan Trypanosoma cruzi and is the main cause of heart failure in endemic areas. This illness attracted worldwide attention due to the presence of symptomatic seropositive subjects in North America, Asia, Oceania, and Europe. In the acute phase of infection, nonspecific signs, and symptoms contribute to miss diagnosis and early etiological treatment. In this phase, the immune response is crucial for parasite control; however, parasite persistence, dysregulated immune response, and intrinsic tissue factors may contribute to the pathogenesis of chronic CD. Most seropositive subjects remain in the indeterminate chronic form, and from 30 to 40% of the subjects develop cardiac, digestive, or cardio-digestive manifestations. Identification of EVs containing T. cruzi antigens suggests that these vesicles may target host cells and regulate cellular processes and the immune response by molecular mechanisms that remain to be determined. Parasite-released EVs modulate the host-parasite interplay, stimulate intracellular parasite differentiation and survival, and promote a regulatory cytokine profile in experimental models of CD. EVs derived from the parasite-cell interaction inhibit complement-mediated parasite lysis, allowing evasion. EVs released by T. cruzi-infected cells also regulate surrounding cells, maintaining a proinflammatory profile. After a brief review of the basic features of EVs, the present study focuses on potential participation of T. cruzi-secreted EVs in cell infection and persistence of low-grade parasite load in the chronic phase of infection. We also discuss the role of EVs in shaping the host immune response and in pathogenesis and progression of CD.
Highlights
IntroductionExtracellular vesicles (EVs) act as cell communicators and immune response modulators and may be employed as disease biomarkers and drug delivery systems
Endosome-borne vesicles are derived from the formation of a multivesicular body (MVB), which is filled with intraluminal vesicles that fuse with the plasma membrane, and are known as exosomes with a size ranging from 50∼150 nm (Théry, 2011)
Increased Extracellular vesicles (EVs) levels in the serum, cerebrospinal fluid, and brain tissue correlate with cognitive impairment in Human immunodeficiency virus (HIV) infection and Alzheimer disease (AD), which are diseases related to neuroinflammation, which is characterized as the effects of peripheral inflammatory cells, i.e., leukocytes, in the central nervous system (CNS)
Summary
Extracellular vesicles (EVs) act as cell communicators and immune response modulators and may be employed as disease biomarkers and drug delivery systems. Despite well-recognized types of cell-to-cell communication, extracellular vesicles (EVs) have emerged in the past 3 decades as an important strategy for delivery of cargo to short or long distances between the cells, acting through EV uptake or receptor-mediated interactions (van Niel et al, 2018). This cell communication process occurs during physiological and pathological processes between healthy cells and microorganisms and is preserved in evolution (Woith et al, 2019). We describe proposed biogenesis of small and large vesicles; no distinction will be made between these vesicles, which are collectively named EVs in the text
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.